% !TEX program = xelatex
% Two-Page CV
% Compile with xelatex -> biber -> xelatex -> xelatex

\documentclass[10pt,a4paper,roman]{moderncv}

% ModernCV themes
\moderncvstyle{classic}  
\moderncvcolor{burgundy}     

% Font package
\usepackage{fontspec}
\setmainfont{STIXGeneral}

% Adjust page margins - tighter for 2-page CV
\usepackage[margin=0.4in]{geometry}
\setlength{\hintscolumnwidth}{2.5cm}

% For tables
\usepackage{longtable}
\usepackage{array}

% Bibliography
\usepackage[sorting=ydnt,defernumbers=true,backend=biber,maxbibnames=3,maxcitenames=3]{biblatex}
\addbibresource{my_publications.bib}

% Style DOIs in burgundy color to match headings
\DeclareFieldFormat{doi}{%
  \textcolor{color1}{%
    \mkbibacro{DOI}\addcolon\space
    \ifhyperref
      {\href{https://doi.org/#1}{\nolinkurl{#1}}}
      {\nolinkurl{#1}}%
  }%
}

% Custom command to extract fields from bibliography
\usepackage{xparse}

% Bold surname in citations
\usepackage{xstring}

\DeclareNameFormat{default}{%
  \ifstrequal{\namepartfamily}{Dunne}
    {\textbf{\namepartfamily}\addcomma\addspace\namepartgiveni}
    {\namepartfamily\addcomma\addspace\namepartgiveni}%
}

% Set page background to slightly off-white with warm yellow tone
\pagecolor[RGB]{255,253,236}

% Reduce spacing
\usepackage{etoolbox}
\patchcmd{\makecvtitle}{\vspace*{-2.3em}}{\vspace*{-3em}}{}{}

% Personal data
\photo[0.9in][0.0pt]{bwphoto.png}
\name{Dr. Ross A.}{Dunne}
\title{Curriculum Vitae (short version) \\ \small{\today}}
\address{brainHealth Manchester}{70 Daisybank Road}{Manchester M14 5QN} 
\email{ross.dunne@gmmh.nhs.uk}
\extrainfo{GMC: 7250794 \\ Specialist Register: 19/8/15}
\social[orcid]{0000-0003-2046-6193}
\social[github]{sadneurons} 
\social[linkedin]{ross-dunne-gmdrc}

\begin{document}

\makecvtitle
\vspace{-1em}

\section{Summary}
\cvline{}{Consultant in Old Age Psychiatry and Clinical Director of Greater Manchester Dementia Research Centre. Established UK's first psychiatrist-led CSF biomarker service (2022), scaled into Manchester Brain Health Centre with £35M industry investment. PI/Co-I on 30+ Phase I-III trials; research portfolio exceeding £15M. Focus: platform trials for disease-modifying therapies, molecular diagnostics, vascular cognitive impairment.}

\section{Education \& Qualifications}
\cventry{2010}{PgDipStat}{Trinity College Dublin}{}{}{}
\cventry{2010}{MRCPsych}{Royal College of Psychiatrists}{}{}{}
\cventry{2005}{MB BCH BAO}{Trinity College Dublin}{}{}{}

\section{Current Appointments}
\cventry{2024--}{NIHR-RDN NW England Dementia Clinical Lead}{}{}{}{}
\cventry{2021--}{Board Member/Dementia Theme Co-Lead}{Geoffrey Jefferson BRC}{}{}{}
\cventry{2020--}{Theme Lead for Dementia}{Health Innovation Manchester}{}{}{}
\cventry{2019--}{Clinical Director}{Greater Manchester Dementia Research Centre}{}{}{}
\cventry{2015--}{Consultant in Old Age Psychiatry}{GMMH Foundation Trust}{}{}{}

\section{Selected Leadership Roles}
\cventry{2019--}{Clinical Director}{Greater Manchester Dementia Research Centre}{}{}{Leading NW's largest dementia research centre (7 staff, 9 ongoing studies). Managing commercial/grant portfolio across Phase I-III trials. Member of national Dementia Trials Network.}
\cventry{2022--}{Founder/Clinical Lead}{Manchester Brain Health Centre}{}{}{Established UK's first psychiatrist-led CSF biomarker clinic. Scaled into comprehensive Brain Health Centre with molecular diagnostics, cardiovascular profiling, and risk reduction interventions. £35M industry investment.}

\section{Key Grants (Recent; £14M+ total)}
\cventry{2026--31}{Treating auditory impairment in MCI}{NIHR PGfAR}{£3.4M}{Co-App}{}
\cventry{2025--30}{AD-SMART Platform Trial}{MRC/DRI/ARUK}{£7.5M}{Co-I}{}
\cventry{2025--27}{Manchester Brain Health Centre}{AlzSoc}{£1.5M}{Clinical Director}{}
\cventry{2024--29}{READ-OUT Real world outcomes}{ARUK/AlzSoc/NIHR}{£4.5M}{Site PI}{}
\cventry{2023--28}{ANTLER75+ Depression withdrawal}{NIHR HTA}{£1.95M}{Site PI}{}
\cventry{2023--26}{All-in-One MCI imaging}{Alzheimer's Society}{£384K}{PI}{}

\section{Awards \& Honors}
\cventry{2025}{HSJ Award}{Best NHS Collaboration \& Best Pharmaceutical Partnership}{}{}{}
\cventry{2024}{ACCIA National Clinical Impact Award Level N1}{}{}{}{}
\cventry{2023}{HSJ Award}{Modernising Diagnostics (brainHealth Manchester)}{}{}{}

\section{Clinical Trials Experience}
\cvline{Overview}{PI/Co-I on 30+ trials across AD monoclonal antibodies (Aducanumab, Gantenerumab, AL002), AD therapeutics (semaglutide, tau ASO), neuropsychiatric symptoms, and biomarker/platform studies (AD-SMART, READOUT, AllinOne). Extensive Phase I-III experience.}
\cvline{Current}{Gabriella (Roche), CELIA (Biogen), AD-SMART (MRC), ANTLER75+ (NIHR), CICERO (NIHR), AllinOne (AlzSoc), READOUT (ARUK/NIHR), ABHAD (BRC)}

\section{Innovation \& Service Development}
\cvline{Brain Health}{Established UK's first psychiatrist-led CSF biomarker clinic (2022). Personally developed lab protocols, scaled into Manchester Brain Health Centre with comprehensive molecular diagnostics, cardiovascular profiling, and risk reduction using Motivational Interviewing. Advised 10+ UK/international sites on replication.}
\cvline{Regional MDT}{Convened regional MDT (2024) with neurology, neuroradiology, nuclear medicine for safe implementation of monoclonal antibody therapies in AD.}

\section{Selected Publications (h-index: 20+)}
\nocite{dunne2021mild,dunne2023tipping,taylor2023uncoupling,semkovska2016bitemporal,dunne2012systematic}

\printbibliography[heading=none]

\vspace{0.2cm}
\noindent\textit{Full publication list (30+ peer-reviewed articles): available on request or ORCID 0000-0003-2046-6193}

\section{Research Skills}
\cvline{Clinical}{Trial design/coordination, GCP, ethics, lumbar puncture, CSF biomarker processing. Rating scales: RBANS, CDR, ADAS-Cog, MADRS, MMSE, MoCA, PWV, audiometry.}
\cvline{Technical}{R, Python, C++, mixed-effects modelling (lmer), TensorFlow/PyTorch, LaTeX, Linux/BASH, web development (Django, JavaScript). PgDipStat (TCD), ONS Safe Researcher, Google Python certification.}
\cvline{Current Study}{BSc Mathematics (Open University, in progress)}

\section{Teaching \& Training}
\cvline{}{Undergraduate tutor (TCD, Cambridge, Manchester). Faculty member, Neurology Academy Sheffield. Registered trainer/educational supervisor for higher trainees in old age psychiatry.}

\section{Service \& Leadership}
\cvline{UK Brain Health Coalition}{Founder member and Co-Chair (ARUK/AlzSoc). Lead national dissemination of early diagnosis approaches.}
\cvline{Grant Review}{Co-chair, Alzheimer's Society UK (2022--25); Board member ARUK (2023--25), Alzheimer Society Ireland (2023)}
\cvline{Trial Oversight}{TSC member and chair COBALT (NIHR EME). Peer reviewer for journals and NIHR i4i programme.}
\cvline{Editorial}{Guest editor, British Journal of Psychiatry special issue on DMTs in AD (2023)}

\section{Key Collaborations}
\cvline{University of Manchester}{Prof Stuart Allan (Neuroscience, MaVRICS), Prof Adam Greenstein (CV Sciences), Prof Laura Parkes (Neuroimaging, AllinOne), Dr Sasha Philbert (CV Sciences, Na-MRI), Dr Karen Hampson (Vision Science, retinal biomarkers), Dr Jenna Littlejohn (Hearing BRC, ABHAD)}

\section{Professional Memberships}
\cvlistitem{Royal College of Psychiatrists (2010--)}
\cvlistitem{British Geriatric Society (2017--)}
\cvlistitem{International Psychogeriatric Association (2019--)}
\cvlistitem{International Parkinson's and Movement Disorders Society (2018--)}

\section{References}
\cvline{}{Available upon request}

\end{document}
